IVERIC bio, Inc.
ISEEDelisted Jul 11, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001410939
IVERIC bio, Inc. was delisted on Jul 11, 2023; its insiders filed their last Form 4 on Jul 13, 2023; 256 institutions reported holding it in 13F filings for Q2 2023, worth $5.33B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q3 2022
Institutional positions in IVERIC bio, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 213
- +28 vs. Q2 2022
- Shares held
- 125.7M
- +6.46M (+5.4%) vs. Q2 2022
- Total value
- $2.26B
- +$1.11B (+96.7%) vs. Q2 2022
- New holders
- 57
- 69 more added
- Sold out
- 29
- 64 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ISEE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 256 | $5.33B |
| Q1 2023 | 223 | $3.58B |
| Q4 2022 | 225 | $3.15B |
| Q3 2022 | 213 | $2.26B |
| Q2 2022 | 185 | $1.15B |
| Q1 2022 | 163 | $2.02B |
| Q4 2021 | 175 | $2.00B |
| Q3 2021 | 150 | $1.68B |
| Q2 2021 | 128 | $536.9M |
| Q1 2021 | 115 | $495.6M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding IVERIC bio, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citadel Advisors LLC | 2,558,371 | $45.9M | 0.06% | +2,388,227+1,403.7% | Added |
| Redmile Group, LLC | 3,399,900 | $61.0M | 2.37% | +1,881,000+123.8% | Added |
| Price T Rowe Associates Inc | 3,446,354 | $61.8M | 0.01% | +56,214+1.7% | Added |
| Yiheng Capital Management, L.P. | 3,613,254 | $64.8M | 6.10% | −1,445,331−28.6% | Reduced |
| RTW Investments, LP | 3,625,000 | $65.0M | 1.50% | +3,625,000 | New |
| TCG Crossover Management, LLC | 3,877,903 | $69.6M | 20.87% | +963,653+33.1% | Added |
| Deerfield Management Company, L.P. (Series C) | 4,244,098 | $76.1M | 1.52% | −969,902−18.6% | Reduced |
| Janus Henderson Group PLC | 5,113,491 | $91.7M | 0.07% | −3,036,228−37.3% | Reduced |
| Avoro Capital Advisors LLC | 5,900,000 | $105.8M | 1.96% | −1,220,000−17.1% | Reduced |
| Vanguard Group Inc | 6,116,761 | $109.7M | 0.00% | +134,845+2.3% | Added |
| State Street Corp | 6,244,356 | $112.0M | 0.01% | −2,489,234−28.5% | Reduced |
| Deep Track Capital, LP | 7,000,000 | $125.6M | 6.20% | +2,500,000+55.6% | Added |
| BlackRock Inc. | 8,125,064 | $145.8M | 0.00% | +75,466+0.9% | Added |
| Commodore Capital LP | 0 | $0 | 0.00% | −2,409,961−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −1,386,542−100.0% | Sold out |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −1,361,400−100.0% | Sold out |
| Ally Bridge Group (NY) LLC | 0 | $0 | 0.00% | −650,000−100.0% | Sold out |
| Avidity Partners Management LP | 0 | $0 | 0.00% | −430,117−100.0% | Sold out |
| Frazier Life Sciences Management, L.P. | 0 | $0 | 0.00% | −170,000−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −136,875−100.0% | Sold out |
| Banque Pictet & Cie SA | 0 | $0 | 0.00% | −133,317−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −112,605−100.0% | Sold out |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −109,750−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −98,568−100.0% | Sold out |
| Westwood Holdings Group Inc. | 0 | $0 | 0.00% | −57,432−100.0% | Sold out |
| AlphaCrest Capital Management LLC | 0 | $0 | 0.00% | −52,506−100.0% | Sold out |
| Goldstream Capital Management Ltd | 0 | $0 | 0.00% | −46,000−100.0% | Sold out |
| Cinctive Capital Management LP | 0 | $0 | 0.00% | −43,800−100.0% | Sold out |
| Creative Planning | 0 | $0 | 0.00% | −28,790−100.0% | Sold out |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −19,225−100.0% | Sold out |
| Boulder Hill Capital Management LP | 0 | $0 | 0.00% | −18,200−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | – | Sold out |
| Old Mission Capital LLC | 0 | $0 | 0.00% | −12,969−100.0% | Sold out |
| Parametrica Management Ltd | 0 | $0 | 0.00% | −10,905−100.0% | Sold out |
| Picton Mahoney Asset Management | 0 | $0 | 0.00% | −7,200−100.0% | Sold out |
| Vectors Research Management, LLC | 0 | $0 | 0.00% | −3,000−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −3,000−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −1,663−100.0% | Sold out |
| Spire Wealth Management | 0 | $0 | 0.00% | −800−100.0% | Sold out |
| Venture Visionary Partners LLC | 0 | $0 | 0.00% | −147−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −57−100.0% | Sold out |
| PEAK6 Investments LLC | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |